Paeonol attenuates microglia-mediated inflammation and oxidative stress-induced neurotoxicity in rat primary microglia and cortical neurons

Shock

Volumn 37, Issue 3, 2012, Pages 312-318

  Tseng, Yu Ting ^a   Hsu, Ya Yun ^a   Shih, Yu Tzu ^a   Lo, Yi Ching ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

anti inflammation; lipopolysaccharides; microglia; neuroprotection; Paeonol

Indexed keywords

CYCLOOXYGENASE 2; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; OXIDOPAMINE; PEONOL; PROSTAGLANDIN E2; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

ACETOPHENONES; ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CYCLOOXYGENASE 2; FEMALE; HEME OXYGENASE-1; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASES; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84857565714     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31823fe939     Document Type: Article

References (35)

1. Tanaka M, Sotomatsu A, Yoshida T, Hirai S, Nishida A: Detection of superoxide production by activated microglia using a sensitive and specific chemiluminescence assay and microglia-mediated PC12h cell death. J Neurochem 63(1):266-270, 1994. (Pubitemid 24184927)
2. Sawada M, Kondo N, Suzumura A, Marunouchi T: Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 491(2): 394-397, 1989. (Pubitemid 19163393)
3. Moss DW, Bates TE: Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. Eur J Neurosci 13(3):529-538, 2001. (Pubitemid 32158785)
4. Sun GP, Wang H, Xu SP, Shen YX, Wu Q, Chen ZD, Wei W: Anti-tumor effects of paeonol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNF-alpha production. Eur J Pharmacol 584(2-3):246-252, 2008.
5. Chou TC: Anti-inflammatory and analgesic effects of paeonol in carrageenanevoked thermal hyperalgesia. Br J Pharmacol 139(6):1146-1152, 2003.
6. Chae HS, Kang OH, Lee YS, Choi JG, Oh YC, Jang HJ, Kim MS, Kim JH, Jeong SI, Kwon DY: Inhibition of LPS-induced iNOS, COX-2 and inflammatory mediator expression by paeonol through the MAPKs inactivation in RAW 264.7 cells. Am J Chin Med 37(1):181-194, 2009.
7. Hsieh CL, Cheng CY, Tsai TH, Lin IH, Liu CH, Chiang SY, Lin JG, Lao CJ, Tang NY: Paeonol reduced cerebral infarction involving the superoxide anion and microglia activation in ischemia-reperfusion injured rats. J Ethnopharmacol 106(2):208-215, 2006.
8. Lee B, Shin YW, Bae EA, Han SJ, Kim JS, Kang SS, Kim DH: Antiallergic effect of the root of Paeonia lactiflora and its constituents paeoniflorin and paeonol. Arch Pharm Res 31(4):445-450, 2008.
9. Mi XJ, Chen SW, Wang WJ, Wang R, Zhang YJ, Li WJ, Li YL: Anxiolytic-like effect of paeonol in mice. Pharmacol Biochem Behav 81(3):683-687, 2005. (Pubitemid 40966816)
10. Li YJ, Bao JX, Xu JW, Murad F, Bian K: Vascular dilation by paeonolVa mechanism study. Vascul Pharmacol 53(3-4):169-176, 2010.
11. Tsai HY, Lin HY, Fong YC, Wu JB, Chen YF, Tsuzuki M, Tang CH: Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway. Eur J Pharmacol 588(1):124-133, 2008.
12. Li H WS, Yang Q, Xin Y, Cao W, Zang B, Wang JB, Wang TP, Wang M: LC tissue distribution study of paeonol in rats after oral administration. Chromatographia 73(5-6):495-500, 2011.
13. Wu JB, Song NN, Wei XB, Guan HS, Zhang XM: Protective effects of paeonol on cultured rat hippocampal neurons against oxygen-glucose deprivation-induced injury. J Neurol Sci 264(1-2):50-55, 2008.
14. Zhong SZ, Ge QH, Qu R, Li Q, Ma SP: Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice. J Neurol Sci 277(1-2):58-64, 2009.
15. Qian L, Flood PM, Hong JS: Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm 117(8):971-979, 2010.
16. Agostinho P, Cunha RA, Oliveira C: Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des 16(25):2766-2778, 2010.
17. Grossblatt N. Guide for the Care and Use of Laboratory Animals. Washington, DC: Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council, 1996.
18. Sun AY, Chen YM: Oxidative stress and neurodegenerative disorders. J Biomed Sci 5(6):401-414, 1998. (Pubitemid 28559104)
19. Wyss-Coray T, Mucke L: Inflammation in neurodegenerative diseaseVa doubleedged sword. Neuron 35(3):419-432, 2002. (Pubitemid 34879943)
20. Block ML, Hong JS: Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76(2):77-98, 2005. (Pubitemid 41242883)
21. Laubach VE, Shesely EG, Smithies O, Sherman PA: Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92(23):10688-10692, 1995.
22. Liu HE, Chang AS, Teng CM, Chen CC, Tsai AC, Yang CR: Potent antiinflammatory effects of denbinobin mediated by dual inhibition of expression of inducible no synthase and cyclooxygenase 2. Shock 35(2):191-197, 2011.
23. Brown GC: Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 35(Pt 5):1119-1121, 2007. (Pubitemid 350206442)
24. Hoozemans JJ, Rozemuller JM, van Haastert ES, Veerhuis R, Eikelenboom P: Cyclooxygenase-1 and-2 in the different stages of Alzheimer's disease pathology. Curr Pharm Des 14(14):1419-1427, 2008. (Pubitemid 351982549)
25. Teismann P, Tieu K, Choi DK, Wu DC, Naini A, Hunot S, Vila M, Jackson-Lewis V, Przedborski S: Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci USA 100(9):5473-5478, 2003. (Pubitemid 36542729)
26. Shi Y, Tu Z, Tang D, Zhang H, Liu M, Wang K, Calderwood SK, Xiao X: The inhibition of LPS-induced production of inflammatory cytokines by HSP70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways. Shock 26(3):277-284, 2006.
27. Qin B, Cartier L, Dubois-Dauphin M, Li B, Serrander L, Krause KH: A key role for the microglial NADPH oxidase in APP-dependent killing of neurons. Neurobiol Aging 27(11):1577-1587, 2006. (Pubitemid 44349157)
28. Block ML, Li G, Qin L, Wu X, Pei Z, Wang T, Wilson B, Yang J, Hong JS: Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J 20(2):251-258, 2006. (Pubitemid 44933172)
29. Qin L, Liu Y, Wang T, Wei SJ, Block ML, Wilson B, Liu B, Hong JS: NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 279(2):1415-1421, 2004. (Pubitemid 38082669)
30. Bedard K, Krause KH: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87(1):245-313, 2007. (Pubitemid 46209993)
31. Kulich SM, Chu CT: Role of reactive oxygen species in extracellular signalY regulated protein kinase phosphorylation and 6-hydroxydopamine cytotoxicity. J Biosci 28(1):83-89, 2003. (Pubitemid 36268251)
32. Reiter RJ: Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 9(7):526-533, 1995.
33. Choi J, Rees HD, Weintraub ST, Levey AI, Chin LS, Li L: Oxidative modifications and aggregation of Cu,ZnYsuperoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem 280(12):11648-11655, 2005. (Pubitemid 40418479)
34. Mattson MP, Culmsee C, Yu ZF: Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 301(1):173-187, 2000. (Pubitemid 30459864)
35. Niizuma K, Endo H, Chan PH: Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 109(Suppl 1):133-138, 2009.